Analysts have been eager to weigh in on the Financial sector with new ratings on S&P Global (SPGI – Research Report), Victory Capital ...
Truist Securities increased the price target for Vertex Pharmaceuticals (NASDAQ:VRTX) Incorporated (NASDAQ: VRTX), a $121 ...
Scotiabank raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $450 from $433 and keeps a Sector Perform rating on the shares.
Morgan Stanley (NYSE:MS) adjusted its outlook for Victory Capital Holdings, Inc. (NASDAQ: NASDAQ:VCTR), increasing the firm's price target from $63.00 to $68.00. The investment bank maintained its ...
Davis Selected Advisers' 13F portfolio saw changes with stake increases in tech and travel, while reducing in financial and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results